Skip to content

Drug interactions

Apalutamide + Maraviroc

Severity: Major

Apalutamide and Maraviroc: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Apalutamide may markedly reduce maraviroc concentrations because it is a CYP3A4 and P-gp substrate. Subtherapeutic exposure can result in virologic failure.

What this interaction means in plain words

Apalutamide and Maraviroc can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Apalutamide belongs to Endocrine; Maraviroc belongs to Anti Virals.

Evidence level: Moderate

Why it happens

Apalutamide induces CYP3A4 and P-glycoprotein, increasing maraviroc clearance.

What to do

Avoid the combination; if used without a CYP3A4 inhibitor the maraviroc dose generally needs to be increased per labeling. Monitor HIV viral load.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Apalutamide and Maraviroc, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Apalutamide with Maraviroc?

MediHelp rates the interaction as major. Apalutamide and Maraviroc can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Apalutamide may markedly reduce maraviroc concentrations because it is a CYP3A4 and P-gp substrate. Subtherapeutic exposure can result in virologic failure.

How serious is the interaction between Apalutamide and Maraviroc?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination; if used without a CYP3A4 inhibitor the maraviroc dose generally needs to be increased per labeling. Monitor HIV viral load.

What other medicines interact with Apalutamide?

MediHelp also lists interactions of Apalutamide with, for example, Cabotegravir, Cobicistat, Doravirine. The full list is on the Apalutamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in